Henry Schein Profit Margin 2010-2023 | HSIC

Current and historical gross margin, operating margin and net profit margin for Henry Schein (HSIC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Henry Schein net profit margin as of December 31, 2023 is 3.37%.
Henry Schein Annual Profit Margins
Henry Schein Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $9.256B $12.339B
Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.294B 18.55
Becton Dickinson (BDX) United States $67.568B 19.62
West Pharmaceutical Services (WST) United States $27.478B 46.45
Cardinal Health (CAH) United States $25.012B 15.03
Align Technology (ALGN) United States $22.637B 45.65
Cooper (COO) United States $17.896B 27.08
Labcorp (LH) United States $17.083B 14.59
DENTSPLY SIRONA (XRAY) United States $6.298B 16.60
Merit Medical Systems (MMSI) United States $4.253B 24.34
Patterson (PDCO) United States $2.321B 11.12
STAAR Surgical (STAA) United States $2.275B 71.61
CONMED (CNMD) United States $2.236B 21.05
Atrion (ATRI) United States $0.704B 36.25
Lifevantage (LFVN) United States $0.078B 12.60
Pro-Dex (PDEX) United States $0.065B 24.72
Biolase (BIOL) United States $0.005B 0.00